Confirmatory Trials of Accelerated Approval Drugs - Will Imposing Fines Reduce Delays?
作者信息
Daval C Joseph Ross, Kesselheim Aaron S, Cliff Edward R Scheffer
机构信息
From the Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston.
出版信息
N Engl J Med. 2024 Oct 10;391(14):1273-1275. doi: 10.1056/NEJMp2400699. Epub 2024 Oct 5.
PMID:39373384
Abstract
摘要
相似文献
1
Confirmatory Trials of Accelerated Approval Drugs - Will Imposing Fines Reduce Delays?加速批准药物的验证性试验——罚款会减少延误吗？
N Engl J Med. 2024 Oct 10;391(14):1273-1275. doi: 10.1056/NEJMp2400699. Epub 2024 Oct 5.
2
The right to a trial: Should dying patients have access to experimental drugs?审判权：临终患者是否应有权使用实验性药物？
New Yorker. 2006 Dec 18:40-7.
3
FDA under pressure to relax drug rules.美国食品药品监督管理局面临放宽药品规定的压力。
Nature. 2012 Dec 6;492(7427):19. doi: 10.1038/492019a.
4
Patients, physicians, and clinical trials: the other side of the coins.患者、医生与临床试验：硬币的另一面。
J Investig Med. 1999 Sep;47(8):343-57.
5
Drugs with breakthrough status charm investors.具有突破性地位的药物吸引了投资者。
Nat Biotechnol. 2013 Nov;31(11):945-7. doi: 10.1038/nbt1113-945.
6
Balancing US patent and FDA approval processes: strategically optimizing market exclusivity.平衡美国专利与美国食品药品监督管理局的审批流程：战略性地优化市场独占权。
Drug Discov Today. 2004 Jun 15;9(12):509-12. doi: 10.1016/S1359-6446(04)03067-3.
7
New drug law to speed scientific review.新药品法将加快科学审评。
Nature. 1992 Oct 15;359(6396):563. doi: 10.1038/359563a0.
8
Trouble at the office.办公室里的麻烦事。
Nat Biotechnol. 2008 Sep;26(9):967-9. doi: 10.1038/nbt0908-967.
9
Speed, Safety, and Industry Funding - From PDUFA I to PDUFA VI.速度、安全性与行业资助——从处方药用户收费法案I到处方药用户收费法案VI
N Engl J Med. 2017 Dec 7;377(23):2278-2286. doi: 10.1056/NEJMhle1710706.
10
Paying for drug approvals--who's using whom?为药物审批付费——谁在利用谁？
N Engl J Med. 2007 Apr 26;356(17):1697-700. doi: 10.1056/NEJMp078041. Epub 2007 Apr 13.
引用本文的文献
1
Evidence available and used by the Food and Drug Administration for the approval of orphan and nonorphan drugs.美国食品药品监督管理局用于批准孤儿药和非孤儿药的现有证据及所使用的证据。
Health Aff Sch. 2025 Mar 18;3(4):qxaf057. doi: 10.1093/haschl/qxaf057. eCollection 2025 Apr.
Zotero 插件